BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5% | -0.8% | 1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 84% | 84.5% | 89.7% | 85.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 25.7% | 27% | 31.7% | 22.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 148.1% | 16.2% | 21.9% | 12.8% |
| EPS Diluted | 0.61 | 0.07 | 0.09 | 0.05 |
| % Growth | 771.4% | -22.2% | 80% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |